File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Interaction effects between angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers and steroid or antiviral therapies in COVID‐19: A population‐based study

TitleInteraction effects between angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers and steroid or antiviral therapies in COVID‐19: A population‐based study
Authors
Zhou, JTse, GLee, SLiu, TCao, ZZeng, DDLeung, KSKWai, AKCWong, ICKCheung, BMYZhang, Q
Issue Date2021
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/32763
Citation
Journal of Medical Virology, 2021, v. 93 n. 5, p. 2635-2641 How to Cite?
DOI: http://dx.doi.org/10.1002/jmv.26904
Persistent Identifierhttp://hdl.handle.net/10722/300541
ISSN
0146-6615
2023 Impact Factor: 6.8
2023 SCImago Journal Rankings: 1.560
PubMed Central ID
PMC8013691
ISI Accession Number ID
WOS:000626558200001

 

DC FieldValueLanguage
dc.contributor.authorZhou, J-
dc.contributor.authorTse, G-
dc.contributor.authorLee, S-
dc.contributor.authorLiu, T-
dc.contributor.authorCao, Z-
dc.contributor.authorZeng, DD-
dc.contributor.authorLeung, KSK-
dc.contributor.authorWai, AKC-
dc.contributor.authorWong, ICK-
dc.contributor.authorCheung, BMY-
dc.contributor.authorZhang, Q-
dc.date.accessioned2021-06-18T14:53:27Z-
dc.date.available2021-06-18T14:53:27Z-
dc.date.issued2021-
dc.identifier.citationJournal of Medical Virology, 2021, v. 93 n. 5, p. 2635-2641-
dc.identifier.issn0146-6615-
dc.identifier.urihttp://hdl.handle.net/10722/300541-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/32763-
dc.relation.ispartofJournal of Medical Virology-
dc.rightsSubmitted (preprint) Version This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. Accepted (peer-reviewed) Version This is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.titleInteraction effects between angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers and steroid or antiviral therapies in COVID‐19: A population‐based study-
dc.typeArticle-
dc.identifier.emailLeung, KSK: leungksk@hku.hk-
dc.identifier.emailWai, AKC: awai@hku.hk-
dc.identifier.emailWong, ICK: wongick@hku.hk-
dc.identifier.emailCheung, BMY: mycheung@hkucc.hku.hk-
dc.identifier.authorityWai, AKC=rp02261-
dc.identifier.authorityWong, ICK=rp01480-
dc.identifier.authorityCheung, BMY=rp01321-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1002/jmv.26904-
dc.identifier.pmid33638553-
dc.identifier.pmcidPMC8013691-
dc.identifier.scopuseid_2-s2.0-85102198412-
dc.identifier.hkuros322828-
dc.identifier.volume93-
dc.identifier.issue5-
dc.identifier.spage2635-
dc.identifier.epage2641-
dc.identifier.isiWOS:000626558200001-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats